This page shows the details of why an item matched the keywords from your search.
Item Type | Name |
Concept
|
Mice, Nude
|
Academic Article
|
An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis.
|
Academic Article
|
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
|
Academic Article
|
Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
|
Academic Article
|
Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.
|
Academic Article
|
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
|
Academic Article
|
{beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer.
|
Academic Article
|
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.
|
Academic Article
|
Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.
|
Academic Article
|
miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin a5 expression.
|
Academic Article
|
Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype.
|
Academic Article
|
WNT7A/?-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer.
|
Academic Article
|
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.
|
Academic Article
|
The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
|
Academic Article
|
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
|
Academic Article
|
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
|
Academic Article
|
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.
|
Academic Article
|
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer.
|
Academic Article
|
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
|
Academic Article
|
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum.
|
Academic Article
|
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
|
Academic Article
|
Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
|
Academic Article
|
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6.
|
Academic Article
|
Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis.
|
Academic Article
|
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake.
|
Academic Article
|
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
|